Sakaguchi J, Nishino H, Ogawa N, Iwanaga Y, Yasuda S, Kato H, Ito Y
Central Research Laboratories, Hokuriku Seiyaku Co., Ltd., Fukui, Japan.
Chem Pharm Bull (Tokyo). 1992 Jan;40(1):202-11. doi: 10.1248/cpb.40.202.
Novel N-[[dialkylamino)ethoxy]benzyl]benzamide derivatives (II-1-51), derived from the structural modification of metoclopramide (I), were synthesized and examined for their pharmacological activities. Among them, N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide (II-34) which exhibited well balanced gastrointestinal prokinetic and antiemetic activities was selected as a new type of gastrointestinal prokinetic agent.
通过对胃复安(I)进行结构修饰得到了新型N-[[二烷基氨基)乙氧基]苄基]苯甲酰胺衍生物(II-1-51),并对其药理活性进行了研究。其中,具有良好平衡的胃肠促动力和止吐活性的N-[4-[2-(二甲基氨基)乙氧基]苄基]-3,4-二甲氧基苯甲酰胺(II-34)被选为新型胃肠促动力剂。